Published online Oct 14, 2024. doi: 10.3748/wjg.v30.i38.4242
Revised: September 8, 2024
Accepted: September 11, 2024
Published online: October 14, 2024
Processing time: 76 Days and 18.7 Hours
The challenge of diagnosis delay in inflammatory bowel disease (IBD) has emerged as a significant concern for both patients and healthcare professionals. The widely accepted notion that there is an extended time frame from the onset of symptoms to the definitive diagnosis is often attributed to the heterogeneity of IBD and the non-specificity of clinical manifestations. Specific to patients with Crohn’s disease, the issue of delayed diagnosis appears to be more pronounced across different regions globally. The intricate interplay of real-world factors has led to debates regarding the primary contributors to these diagnostic delays. Drawing a comparison solely between patients and physicians and implicating the latter as the predominant influence factor may fall into a simplistic either-or logical trap that may obscure the truth. This letter, grounded in published evidence, explores areas for improvement in a forthcoming paper within the field, hoping to pinpoint the culprit behind the diagnosis delay issue for IBD patients rather than simply attributing it to so-called “physician-dependent factors”. Our objective is to motivate healthcare providers and policymakers in relevant fields to reflect on strategies for addressing this problem to reduce diagnostic delays and enhance patient outcomes.
Core Tip: This letter centers on the pressing matter of diagnostic delays in inflammatory bowel disease, particularly Crohn’s disease. Drawing on a comprehensive evaluation of a forthcoming paper in the field, our editorial posits that addressing the current diagnostic delays in Crohn’s disease hinges on recognizing the myriad complex real-world factors contributing to the issue, particularly emphasizing those behind the so-called “physician-dependent factors”.